Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HBO Effects on Blood Count Recovery and Post-transplant Outcomes Following High-dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma

NCT03398200 is registered in ClinicalTrials.gov with Omar Aljitawi as lead sponsor.

NCT NCT03398200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03398200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HBO Effects on Blood Count Recovery and Post-transplant Outcomes Following High-dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma
Lead sponsor
Omar Aljitawi
Phase
Phase 2
Overall status
Completed
Start date
May 10, 2018
Completion date
March 28, 2023
Enrollment
99 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma